Home/ Stocks/ ZTS

ZOETIS INC.

ZTS XNYS

$71.40 +0.61 (+0.85%) ▲ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$29.50B

About ZOETIS INC.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 14.5K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$2.47B	$691.00M	$1.65
Q1 2026	$2.26B	$601.00M	$1.42
FY 2025	$9.47B	$2.67B	$6.03
Q3 2025	$2.40B	$721.00M	$1.63

Related Market News

No specific coverage for ZTS yet. Check out our latest market news or earnings calendar.

Get ZTS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ZOETIS INC..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.